论文部分内容阅读
β_(-2)M测定用于多种疾病的诊断。本文96例正常人测定值1.60±0.32(0.63~2.02)μg/ml,9例急性肾炎sβ_2-M阳性8例。uβ_2-M测定8例,阳性4例,肾图5例均为阴性,29例尿毒症,血和尿β_2-M阳性率分别为89.65%和86.95%,17例肾图均为阳性。β_2-M是早期诊断糖尿病性肾病的可靠指标,判断白血病,淋巴瘤等疾病的治疗效果,预测复发,并有利于自身免疫甲状腺病的检出。恶性肿瘤细胞能合成并释放较多的β_2-M使血中β_2-M增高。各种肝病患者血清β_2-M有不同程度增加,以肝硬化为最明显。
β _ (- 2) M assay for the diagnosis of a variety of diseases. 96 cases of normal people measured 1.60 ± 0.32 (0.63 ~ 2.02) μg / ml, 9 cases of acute nephritis sβ_2-M positive in 8 cases. Uβ_2-M was detected in 8 cases, 4 cases were positive, 5 cases were negative in renal mapping. The positive rates of β_2-M in 29 cases of uremia, blood and urine were 89.65% and 86.95%, respectively. β_2-M is a reliable indicator of early diagnosis of diabetic nephropathy, to determine the treatment of leukemia, lymphoma and other diseases, predict recurrence, and is conducive to the detection of autoimmune thyroid disease. Malignant tumor cells can synthesize and release more β_2-M to increase blood β_2-M. Serum β_2-M in patients with various liver diseases increased to varying degrees, with cirrhosis as the most obvious.